DEFA14A ·Filed Mar 17, 2026

HLF

HERBALIFE LTD.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001213900-26-029134
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine filing with no immediate financial implications. Traders should monitor for any changes in board composition or executive compensation that could signal strategic shifts, but no action is required based on this document alone.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
HLF ▼ -19.31% at T+60d
NEUTRAL call ✗ call lost -19.31% · α vs SPY -30.84% · entry $15.12 → $12.20
Entry anchored
Mar 17, 03:59 PM ET
via exchange tick
T+1d
-1.52%
call -1.52% · α -1.26%
$14.89
settled 7mo ago
T+5d
+1.19%
call +1.19% · α +1.91%
$15.30
settled 6mo ago
T+20d
+6.94%
call +6.94% · α +0.90%
$16.17
settled 6mo ago
T+60d
-19.31%
call -19.31% · α -30.84%
$12.20
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Herbalife Ltd. (HLF) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for April 30, 2026. The filing outlines the voting items, which include the election of 11 directors, an advisory vote on executive compensation, and the ratification of PricewaterhouseCoopers LLP as the company's independent auditor. Shareholders are encouraged to vote by April 29, 2026.

Key Facts

  • Herbalife Ltd. is holding its 2026 Annual Meeting on April 30, 2026.
  • The primary voting items include the election of 11 directors, an advisory vote on executive compensation, and the ratification of the independent auditor.
  • Shareholders must vote by April 29, 2026, to have their votes counted.
  • The filing is a routine proxy statement, which is a standard regulatory requirement for publicly traded companies.

Financial Impact

No direct financial impact from this filing.

Risk Factors

  • Routine proxy filings generally do not carry significant market risk.
  • Changes in board composition or executive compensation, if any, could have long-term strategic implications, but these are not detailed in this filing.

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001213900-26-029134
Document: 0001213900-26-029134-index-headers.html0001213900-26-029134
Document: 0001213900-26-029134-index.html0001213900-26-029134
Document: 0001213900-26-029134.txt0001213900-26-029134
6 reports for HLF
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+5▲ +5.75%May 21, 2026
Filters
Rows
Reports for HLF — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
8-K
BEARISH ★ 5/10
$10.99 $12.44▼ −13.19%▼ −13.38%$12.56 (−14.29%)
May 21, 2026
19w ago
Insider Cluster
BEARISH ★ 5/10
$12.69 $12.20▲ +3.90%▲ +4.23%$12.56 (+1.02%)
May 6, 2026
21w ago
8-K
BULLISH ★ 7/10
$14.49 $11.39▼ −21.39%▼ −24.53%$12.56 (−13.32%)
May 1, 2026
22w ago
8-K
NEUTRAL ★ 5/10
$15.82 $11.90▼ −24.78%▼ −30.42%$12.56 (−20.61%)
Apr 14, 2026
24w ago
8-K
BULLISH ★ 8/10
$16.67 $13.51▼ −18.96%▼ −25.25%$12.56 (−24.66%)
Mar 17, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$15.12 $16.17▲ +6.94%▲ +0.90%$12.56 (−16.93%)
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (56h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access